Last reviewed · How we verify
NCT03097042
Comparison of Two Different Catheter Withdrawal Technique
NA trial testing Embryo transfer any further manipulation in Embryo in 200 participants. Completed in 31 August 2017.
1 August 2017
Quick facts
| Lead sponsor | Zeynep Kamil Maternity and Pediatric Research and Training Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 200 |
| Start date | 1 February 2017 |
| Primary completion | 1 August 2017 |
| Estimated completion | 31 August 2017 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Embryo transfer any further manipulation
- Embryo transfer with catheter Manipulation
Conditions studied
- Embryo — all drugs for Embryo →
- Catheter Site Discharge — all drugs for Catheter Site Discharge →
Sponsor
Zeynep Kamil Maternity and Pediatric Research and Training Hospital
Who can join
Adults 20 to 40, female only, with Embryo or Catheter Site Discharge. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The embryologist will oad the embryos into the catheter at the right position, then the catheter will be slowly pushed through the cervical canal, 1-2 cm beneath the fundus 5.5 cm away from the cervical external os.The embryos will be delivered by pushing the plunger of the syringe from the mid-cavitary positioned catheter and keeping the plunger pushed down. Study Group: The catheter will be pulled back slowly and without rotation with the plunger still pushed forward. Control Group: The catheter will be pulled back slowly with a 360°rotation with the plunger kept pushed forward.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Prospective Randomized Trial Comparing Embryo Transfers of Cases with and without Catheter Rotation during Its Withdrawal.
Yayla Abide C, Ozkaya E, Sanverdi I, Bostancı Ergen E, et al · · 2018 · cited 5× · PMID 29758560 · DOI 10.1159/000489493
Verify or expand the search:
- PubMed search for NCT03097042
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Zeynep Kamil Maternity and Pediatric Research and Training Hospital trials
Trials by the same sponsor.
- NCT05786352 — Outcomes of Enhanced Recovery After Cesarean (ERAC) Protocol · NA · unknown
- NCT07312617 — Short-Term Outcomes of TOT, TVT, and Burch Surgery Assessed by Transperineal Ultrasound · NA · completed
- NCT05558046 — Predictive Value of Granulosa Cell DNA Damage in the Success of Assisted Reproductive Technique · unknown
- NCT05558852 — Laparoscopic Central and Anterior Compartment Prolapse Surgery: A Meshless Sacrocolpopexy Technique · NA · unknown
- NCT04888091 — Comparison of the Effect of Cervical Mucus Cleaning Method Applied Before Embryo Transfer on Pregnancy Rates. · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03097042 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Zeynep Kamil Maternity and Pediatric Research and Training Hospital
- Last refreshed: 31 January 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03097042.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing